Effect of integrative Unani personalized regimen in reducing risk factors of Metabolic Syndrome. A randomized open-labeled controlled clinical study (Record no. 17235)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | a |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20220730143444.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 220730b xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | AIKTC-KRRC |
| Transcribing agency | AIKTC-KRRC |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 17411 |
| Personal name | Zarnigar, Nida Talat |
| 245 ## - TITLE STATEMENT | |
| Title | Effect of integrative Unani personalized regimen in reducing risk factors of Metabolic Syndrome. A randomized open-labeled controlled clinical study |
| 250 ## - EDITION STATEMENT | |
| Edition statement | Vol.16(2), Apr-Jun |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Mandsaur |
| Name of publisher, distributor, etc. | BRNSS Publication Hub. |
| Date of publication, distribution, etc. | 2022 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 159-171p. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Background: Metabolic syndrome is a cluster of risk factors for CVD and diabetes. The number of individuals with metabolic syndrome continues to rise. The current study aimed to test the efficacy and safety of an Integrative Unani personalized regimen (IUPR) in reducing the risk factors of metabolic syndrome. Materials and Methods: Patients according to NCEP ATP III criteria were selected, 50 patients (30 in the test group and 20 in the control group) completed the study. The test group was treated with an IUPR and the control group was treated for respective risk factors with standard drugs for 2 months. The response was measured by changes in TC, TG, HDL, FBS, BP, WC, and Weight. Results: IUPR was found superior in reducing body weight, waist circumference, and BP (P < 0.01), equivalent in reducing serum triglyceride and fasting blood sugar level and inferior in reducing total cholesterol compared to standard drugs provided for respective risk factors after 2 months of intervention. HDL increased by 1.033 mg/dl in the test and decreased in the control group by 4.850 mg/dl. Conclusion: In metabolic syndrome lipid storage increases due to the deterrence of the pathological mechanisms. Unani regimen caused a reduction in risk factors of the metabolic syndrome might be by attenuation in physiological changes possibly by reverting rate-limiting enzymes and increasing energy expenditure. Long-term high-quality trials with dietary modification are needed to get optimal results. Key words: Metabolic syndrome, Sue mizajbarid, Integrative unani personalized regimen |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| 9 (RLIN) | 4639 |
| Topical term or geographic name entry element | PHARMACEUTICS |
| 773 0# - HOST ITEM ENTRY | |
| International Standard Serial Number | 0973-8258 |
| Title | International journal of green pharmacy |
| Place, publisher, and date of publication | Mandsaur B.R. Nahata Smriti Sansthan |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | https://www.greenpharmacy.info/index.php/ijgp/article/view/3250 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | |
| Koha item type | Articles Abstract Database |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection code | Permanent Location | Current Location | Shelving location | Date acquired | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Not For Loan | Reference | School of Pharmacy | School of Pharmacy | Archieval Section | 2022-07-30 | 2022-1237 | 2022-07-30 | 2022-07-30 | Articles Abstract Database |